Top Analyst Reports for Texas Instruments, Mondelez & Colgate

Tuesday, January 16, 2018

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments (TXN), Mondelez (MDLZ) and Colgate (CL). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Buy-rated Texas Instruments’ shares have gained +51.3% over the last 12 months, outperforming the Zacks General Semiconductor industry which has gained +50.1% over the same period. The Zacks analyst likes its prudent R&D investments in several high margin, high-growth areas of the analog and embedded processing markets. This is gradually increasing its exposure to industrial and automotive markets and dollar content at customers, while reducing exposure to volatile consumer/computing markets.

Margins continue to expand on secular strength in the auto and industrial markets, a stronger mix of analog and embedded processing products and manufacturing efficiencies that include growing 300-millimeter Analog output.

Of late, estimates have remained stable ahead of the company's Q4 earnings release. The company has positive record of earnings surprises in recent quarters. However, increasing competition, unfavorable currency effect and a high debt load remain concerns.

(You can read the full research report on Texas Instruments here >>>).

Shares of Buy-rated Mondelez have lost -5.4% in the last one year, compared with the -4.4% dip of the Zacks Food Preparation industry. However, the Zacks analyst likes Mondelez’s attractive portfolio of iconic brands and its commanding presence in impulsive categories and fast-growing emerging markets.

The company's margins have remained constantly strong backed by cost savings and productivity gains. Mondelez’s earnings estimates for 2018 have been trending upward in the last 30 days. This reflects analysts' optimism on the stock's prospect.

However, Mondelez’s volumes have been hurt since 2014 by the elasticity impact from higher pricing and category weakness because of soft consumer demand. Moreover, with a significant portion of its sales coming from the international markets, currency is a significant top-line headwind.

(You can read the full research report on Mondelez here >>>).

Buy-rated Colgate’s shares are up +2.8% over the last six months, outperforming the Zacks Consumer Staples sector, which has gained +1.5% over the same period. The Zacks analyst likes the progress made on its Global Growth and Efficiency Program along with additional savings anticipated from the recent expansion of the program.

However, the company has been infamous among investors with its meet or beat earnings track record. Though it posted in-line earnings and topped sales estimates in third-quarter 2017, margins remained strained due to increased raw material and packaging costs, as well as higher advertising expenses. Further, it anticipates these costs to persist and impact margins in 2017.

The company also perked up its costs guidance related to charges arising from the expansion and extension of the Global Growth and Efficiency Program through Dec 31, 2019. Nonetheless, Colgate’s shareholder-friendly moves remain noteworthy. Estimates have been stable lately ahead of the fourth quarter earnings release.

(You can read the full research report on Colgate here >>>).

Other noteworthy reports we are featuring today include Infosys (INFY), Tesla (TSLA) and Applied Materials (AMAT).

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Texas Instruments (TXN) Benefits From Strong Auto Demand

Mondelez's (MDLZ) Margins Strong on Cost Saving Initiatives

Colgate's (CL) Innovative Products to Boost Market Share

Featured Reports

WEC Energy (WEC) to Gain From Investments, Demand Drop a Woe

The Zacks analyst believes WEC Energy has gained and will benefit from its $11.8B investment to fortify its existing operations. But drop in electricity volume supplied to customers is a concern.

Applied Materials (AMAT) Benefits from Strong Display Demand

Per the Zacks analyst, Applied Materials is gaining from growing opportunities on the semiconductor front, strong demand for display devices, differentiated products and innovation strategy.

Life Science Assets to Stoke Growth for Alexandria (ARE)

Per the Zacks analyst, Alexandria is anticipated to ride the growth curve on robust fundamentals in the life-science industry which help it enjoy high occupancy and generate steady rental revenues.

BioMarin (BMRN) Drugs Enjoy Strong Demand, Pipeline Solid

BioMarin's key drugs, Vimizim and Kuvan, enjoy strong patient demand trends. Per the Zacks analyst, BioMarin has an impressive rare-disease pipeline with pegvaliase approval expected in 2018.

Citrix (CTXS) Buoyed by SaaS Revenue Growth Amid Cost Woes

The Zacks analyst is impressed by the strong growth in Software-as-a-Service (SaaS) revenues.

RCM Unit Boosts Cerner (CERN) Amid Cutthroat Competition

The Zacks analyst believes that Cerner has growth opportunities in the Revenue Cycle Management (RCM) suite of solutions.

Principal (PFG) Set to Grow on Segmental Strength, Costs Ail

Per the Zacks analyst, Principal is set to grow on segmental strength and solid asset management.

New Upgrades

Marathon (MPC) to Benefit from Accretive Dropdown to MPLX

The Zacks analyst believes that Marathon Petroleum's plan to dropdown assets worth $8.1 billion to its midstream partnership MPLX will boost its cash flows, fueling buybacks and higher dividends.

Strong Services & Software, Client Wins Aid Infosys (INFY)

Per the Zacks analyst, impressive traction of Infosys' new high-growth services and software business, coupled with lucrative client wins, continue to lend momentum to the company's growth.

Dollar Tree's (DLTR) Pricing & Expansion Plan to Boost Sales

Dollar Tree has a remarkable comparable sales trend, delivering 39 straight quarters of positive comps. Per the Zacks analyst, competitive pricing and strategic store expansion should aid sales.

New Downgrades

Weak Canada Operations, Higher Expenses Ail Grainger (GWW)

Per the Zacks analyst, sustained weakness in Canada operations and inflationary expenses due to incremental investments in digital marketing will weigh on Grainger's results in the near term.

eBay (EBAY) Faces Tough Competition, Integration Risks

The Zacks analyst believes that integration risks and increasing competition from Alibaba and other smaller players are major concerns for eBay.

Model 3 Production Delays & High Costs Hurt Tesla (TSLA)

Tesla announced Model 3 production delays twice leading to mismatch between actual number of reservations and delivery. Per the Zacks analyst, customers have become skeptical due to this target miss.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Texas Instruments Incorporated (TXN) : Free Stock Analysis Report
 
Tesla Inc. (TSLA) : Free Stock Analysis Report
 
Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report
 
Infosys Limited (INFY) : Free Stock Analysis Report
 
Colgate-Palmolive Company (CL) : Free Stock Analysis Report
 
Applied Materials, Inc. (AMAT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research